Brian G. Feagan, MD

Western University, Canada

Poster(s):

• P4275 - Single Ascending Dose Results From a Phase 1 Clinical Trial of BT-600, a Combination Product of the NaviCap Targeted Oral Delivery Platform and Tofacitinib
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET